Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Evolent Health Inc.

    NYSE: EVH · Real-Time Price · USD
    8.26
    0.08 (0.98%)
    At close: Jun 17, 2025, 10:21 AM

    Evolent Health Statistics

    Share Statistics

    Evolent Health has 117.4M shares outstanding. The number of shares has increased by 0.33% in one year.

    Shares Outstanding

    n/a
    		 117.4M

    Shares Change (YoY)

    n/a
    		 0.33%

    Shares Change (QoQ)

    n/a
    		 0.02%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 114.29M

    Failed to Deliver (FTD) Shares

    n/a
    		 85

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 17.46M, so 14.87% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 17.46M

    Short % of Shares Out

    n/a
    		 14.87%

    Short % of Float

    n/a
    		 15.05%

    Short Ratio (days to cover)

    n/a
    		 9.46

    Valuation Ratios

    The PE ratio is -20.94 and the forward PE ratio is 14.02. Evolent Health's PEG ratio is 0.57.

    PE Ratio

    n/a
    		 -20.94

    Forward PE

    n/a
    		 14.02

    PS Ratio

    n/a
    		 0.51

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 1.29

    P/FCF Ratio

    n/a
    		 -210.54

    PEG Ratio

    n/a
    		 0.57
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Evolent Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.71.

    Current Ratio

    n/a
    		 0.85

    Quick Ratio

    n/a
    		 0.85

    Debt / Equity

    n/a
    		 0.71

    Debt / EBITDA

    n/a
    		 8.41

    Debt / FCF

    n/a
    		 -116.46

    Interest Coverage

    n/a
    		 -1.64

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $567,720.22

    Profits Per Employee

    n/a
    		 $-13,694

    Employee Count

    n/a
    		 4,500

    Asset Turnover

    n/a
    		 1

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.41M

    Effective Tax Rate

    n/a
    		 2.24%

    Stock Price Statistics

    The stock price has increased by -62.3% in the last 52 weeks. The beta is 0.89, so Evolent Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.89

    52-Week Price Change

    n/a
    		 -62.3%

    50-Day Moving Average

    n/a
    		 8.96

    200-Day Moving Average

    n/a
    		 14.52

    Relative Strength Index (RSI)

    n/a
    		 45.72

    Average Volume (20 Days)

    n/a
    		 2,164,573

    Income Statement

    In the last 12 months, Evolent Health had revenue of 2.55B and earned -61.62M in profits. Earnings per share was -0.81.

    Revenue

    n/a
    		 2.55B

    Gross Profit

    n/a
    		 367.35M

    Operating Income

    n/a
    		 -40.48M

    Net Income

    n/a
    		 -61.62M

    EBITDA

    n/a
    		 84.85M

    EBIT

    n/a
    		 -38.31M

    Earnings Per Share (EPS)

    n/a
    		 -0.81
    Full Income Statement

    Balance Sheet

    The company has 104.2M in cash and 713.67M in debt, giving a net cash position of -609.47M.

    Cash & Cash Equivalents

    n/a
    		 104.2M

    Total Debt

    n/a
    		 713.67M

    Net Cash

    n/a
    		 -609.47M

    Retained Earnings

    n/a
    		 -780.82M

    Total Assets

    n/a
    		 2.65B

    Working Capital

    n/a
    		 -11.16M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 18.77M and capital expenditures -24.89M, giving a free cash flow of -6.13M.

    Operating Cash Flow

    n/a
    		 18.77M

    Capital Expenditures

    n/a
    		 -24.89M

    Free Cash Flow

    n/a
    		 -6.13M

    FCF Per Share

    n/a
    		 -0.05
    Full Cash Flow Statement

    Margins

    Gross margin is 14.38%, with operating and profit margins of -1.58% and -2.41%.

    Gross Margin

    n/a
    		 14.38%

    Operating Margin

    n/a
    		 -1.58%

    Pretax Margin

    n/a
    		 -2.47%

    Profit Margin

    n/a
    		 -2.41%

    EBITDA Margin

    n/a
    		 3.32%

    EBIT Margin

    n/a
    		 -1.58%

    FCF Margin

    n/a
    		 -0.24%

    Dividends & Yields

    EVH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EVH is $15, which is 83.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 83.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 14
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.67

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist